Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker

por Levin, Rachel A., Lund, Maria E., Truong, Quach, Wu, Angela, Shore, Neal D., Saltzstein, Daniel R., Concepcion, Raoul S., Paivanas, Thomas A., van Breda, Arletta, Beebe-Dimmer, Jennifer, Ruterbusch, Julie J., Wissmueller, Sandra, Campbell, Douglas H., Walsh, Bradley J.
Publicado 2018